Sarepta Therapeutics, Inc. (SRPT) stock analysis

In our weekly check, Sarepta Therapeutics, Inc. is graded D (A to F). Of 23 checks on debt, profit, cash flow and trend: 6 pass, warnings: 7, red flags: 10.

About Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as SRPT.

What our checks show for SRPT

Red flags

Warning signs

Strengths

Similar companies

VIR · STOK · NRIX · QURE · RARE · PGEN

Questions

What grade does Sarepta Therapeutics, Inc. (SRPT) have?

In our weekly check, Sarepta Therapeutics, Inc. is graded D (A to F). Of 23 checks on debt, profit, cash flow and trend: 6 pass, warnings: 7, red flags: 10. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of SRPT stock?

This week's biggest flags for Sarepta Therapeutics, Inc.: Weak interest cover, Gross margin falling, Profits not backed by cash. In total 17 of 23 checks show a warning or a red flag.

What does Sarepta Therapeutics, Inc. do?

Sarepta Therapeutics, Inc. is a Healthcare company (Biotechnology) based in the United States, listed on NASDAQ as SRPT.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis